Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG MedAvanteProPhase, explains why this is the case. She also discusses, among other topics, how clinical trial metrics haven’t always kept pace with scientific innovation.
In the field of mental health, there is a discrepancy between how research is conducted and how care is del...
Request a Genetics in Clinical Trials training sessionWhat You'll Learn
Most Recent Flipbooks
WCG has developed and validated the industry-leading Placebo Response Reduction training program.